The US Food and Drug Administration has granted approval to Bristol-Myers Squibb’s drug Cobenfy® (xanomeline and trospium ...

CluePoints continues to transform clinical trial review and leverage its industry-leading software to enhance the interrogation, analysis ...

Shares of Establishment Labs Holdings Inc. (ESTA) were surging more than 21 percent in pre-market on Friday to $50.22, after its ...

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

The FDA announced that it has accepted the supplemental sNDA for roflumilast foam 0.3% in those with scalp and body psoriasis over 12.

Vice President Kamala Harris is making her first visit to the U.S.-Mexico border since becoming the Democratic presidential ...

Hundreds of foods are recalled by the FDA every year. Food recalls could fall into different categories, depending on how ...

Schizophrenia causes persistent delusions and hallucinations and significantly impairs the way patients perceive reality.

Announces completion of enrollment in its oral allergen challenge study for the development of its late-stage pipeline program, Anaphylm™ ...

The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers ...

Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This ...

The Bristol Myers Squibb medicine is said relieve symptoms without causing some of the harsh side effects of drugs already in use. Meanwhile, thousands of patients allege in a lawsuit that drugs used ...